Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950172-04-002133
Filing Date
2004-09-10
Accepted
2004-09-10 11:17:04
Documents
1
Effectiveness Date
2004-09-10

Document Format Files

Seq Description Document Type Size
1 chi420065.txt DEFA14A 5017
  Complete submission text file 0000950172-04-002133.txt   6567
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: DEFA14A | Act: 34 | File No.: 001-12493 | Film No.: 041024264
SIC: 2836 Biological Products, (No Diagnostic Substances)